Raised endothelin 1 levels in patients with colorectal liver metastases

British Journal of Surgery

Volumn 85, Issue 4, 1998, Pages 502-506

  Shankar, A ^a   Loizidou, M ^a   Aliev, G ^b   Fredericks, S ^c   Holt, D ^c   Boulos, P B ^a   Burnstock, G ^b   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; THROMBOMODULIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TUMOR CELL; TUMOR GROWTH;

EID: 0031925028     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00660.x     Document Type: Article

References (28)

1. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989; ii: 53-4 (Letter).
2. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension. N Engl J Med 1990; 323: 1486-7 (Letter).
3. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma - marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 1989; 161: 562-7.
4. Ishibashi M, Fujita M, Nagai K, Kako M, Furue H, Haku E et al. Production and secretion of endothelin by hepatocellular carcinoma. J Clin Endocrinol Metab 1993; 76: 378-83.
5. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-8.
6. + exchange, c-fos expression, and mitogenesis in rat mesanglial cells. J Clin Invest 1989; 83: 708-12.
7. Kusuhara M, Yamaguchi K, Ohnishi A, Abe K, Kimura S, Oona H et al. Endothelin potentiates growth factor-stimulated DNA synthesis in Swiss 3T3 cells. Jpn J Cancer Res 1989; 80: 302-5.
8. Shichiri M, Hirata Y, Nakajima T, Ando K, Imai T, Yanagisawa M et al. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J Clin Invest 1991; 87: 1867-71.
9. Kar S, Yousem SA, Carr BI. Endothelin-1 expression by human hepatocellular carcinoma. Biochem Biophys Res Commun 1995; 216: 514-19.
10. Inagaki H, Bishop AE, Eimoto T, Polak JM. Autoradiographic localization of endothelin-1 binding sites in human colonic cancer tissue. J Pathol 1992; 168: 263-7.
11. Aliev G, Mironov A, Cirillo R, Mironov A Jr, Gorelova E, Prosdocimi M. Evidence for the presence of early vascular lesions in newborn Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 1993; 101: 17-24.
12. Sternberger LA. Immunohistochemistry. 2nd ed. New York: John Wiley, 1979.
13. Loesch A, Burnstock G. Ultrastructural localization of nitric oxide synthase in intima of rabbit aorta. Endothelium 1991; 1: 23-9.
14. Loesch A, Bodin P, Burnstock G. Colocalization of endothelin, vasopressin and serotonin in cultured endothelial cells of rabbit aorta. Peptides 1991; 12: 1095-103.
15. Ashraf S, Crowe R, Loizidou MC, Turmaine M, Taylor I, Burnstock G. The absence of autonomic perivascular nerves in human colorectal liver metastases. Br J Cancer 1996; 73: 349-59.
16. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
17. Howard PG, Plumpton C, Davenport AP. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 1992; 10: 1379-86.
18. Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J et al. Endothelin-1 in human skin, immunohistochemical, receptor binding, and functional studies. J Cardiovasc Pharmacol 1991; 17(Suppl 7): S467-70.
19. Bluhm RE, Frazer MG, Vore M, Pinson CW, Badr KF. Endothelins 1 and 3: potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology 1993; 18: 961-8.
20. Ghandi CR, Stephenson K, Olson MS. Endothelin, a potent peptide agonist in the liver. J Biol Chem 1990; 265: 17 432-5.
21. Giaid A, Saleh D, Yanagisawa M, Forbes RD. Endothelin-1 immunoreactivity and mRNA in transplanted human heart. Transplantation 1995; 59: 1308-13.
22. Huribal M, Kumar R, Cunningham ME, Sumpio BE, McMillen MA. Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1994; 1: 184-7.
23. Prehn RT. The inhibition of tumor growth by tumor mass. Cancer Res 1991; 51: 2-4.
24. Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
25. Hemingway DM, Cooke TG, Grime SJ, Nott DM, Jenkins SA. Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats. Br J Surg 1991; 78: 326-30.
26. Leen A, Angerson W, Wotherspoon H, Moule B, Cooke TG, McArdle CS. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of post-operative follow-up results. Radiology 1995; 195: 113-16.
27. Warren HW, Angerson WJ, Leen E, Carter R, McArdle CS, Cooke TG. Haemodynamic changes associated with colorectal liver metastases; evidence of a humoral mediator. Br J Surg 1993; 80: 1461 (Abstract).
28. Leen E, Angerson WG, Cooke TG, McArdle CS. Prognostic power of Doppler perfusion index in colorectal cancer. Correlation with survival. Ann Surg 1996; 223: 199-203.